GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
48 hedge funds and large institutions have $79.4M invested in Genocea Biosciences, Inc. in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $25K
Holders
48
Holding in Top 10
1
Calls
–
Puts
$25K
Top Buyers
| 1 | +$3.49M | |
| 2 | +$200K | |
| 3 | +$154K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$113K |
Top Sellers
| 1 | -$3.19M | |
| 2 | -$512K | |
| 3 | -$334K | |
| 4 |
Millennium Management
New York
|
-$334K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$236K |